Tag

Biomarin

All articles tagged with #biomarin

business25 days ago•19 min saved

BioMarin to Acquire Amicus for $4.8B, Boosting Rare Disease Leadership and Growth

BioMarin is acquiring Amicus Therapeutics for $4.8 billion to expand its portfolio in rare disease treatments, including marketed products Galafold and Pombiliti + Opfolda, which generated $599 million in revenue over the past four quarters. The deal aims to accelerate revenue growth, diversify BioMarin's product offerings, and create shareholder value, with the transaction expected to close in Q2 2026 and be immediately accretive to earnings.

via BioMarin Pharmaceutical|

#acquisition #amicus-therapeutics #biomarin

healthcare2 years ago•0 min saved

FDA Approves BioMarin's Gene Therapy Roctavian for Hemophilia A

The FDA has approved BioMarin's gene therapy, Roctavian, for the treatment of hemophilia A, following a turbulent regulatory journey that included a surprise rejection in 2020 and a review extension earlier this year. BioMarin aims to commercialize Roctavian and hopes it will become a key blockbuster drug, potentially doubling the company's revenues to $4 billion to $5 billion by the middle of the decade. The list price for the therapy has not been disclosed yet.

via Endpoints News|

#biomarin #commercialization #fda-approval